NCT00207012View on ClinicalTrials.gov

MAD Refractory: Solid Tumor QD w/o Break

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

February 28, 2006

Conditions
HER2 or EGFR Expressing Advanced Solid Malignancies
Interventions
DRUG

BMS-599626

Trial Locations (2)

Unknown

Local Institution, Villejuif

Local Institution, Barcelona

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY